You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
In vitro release study of timolol from novel hpmc/ha composite film for glaucoma treatment
- At: Glasgow (Scotland) (2018)
- Type: Poster
- Poster code: POS-FDP-020
- By: TIGHSAZZADEH, Mo (University of Greenwich, Chemical, Pharmaceutical & Environmental Sciences)
- Co-author(s): Mo Tighsazzadeh
Joshua Boateng - Abstract:
Background
For ocular drug delivery, topical eye drops are the most commonly used dosage form; however, only 5% of the applied dose is absorbed into the eye. Therefore, a more effective drug delivery system is required for severe chronic eye conditions such as glaucoma to provide appropriate bioavailability.
Methods
Optimised 1.5% (w/v) HPMC and 1%.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026